Preetam Shah insider trades

Open-market stock purchases and sales by Preetam Shah, See Remarks at Elicio Therapeutics, Inc, from SEC Form 4 filings since Sep 6, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -70%.

Recent trades

DateStockTradeValue
Jul 16, 2026ELTX Elicio Therapeutics, IncBought (not open market)—
Feb 2, 2026ELTX Elicio Therapeutics, IncBought (not open market)—
Feb 2, 2026ELTX Elicio Therapeutics, IncBought (not open market)—

Companies traded

  • ELTX Elicio Therapeutics, Inc: other filings, last Jul 16, 2026
  • CDTX Cidara Therapeutics, Inc: 1 buy, 3 sales, last Sep 30, 2024
  • BCLI Brainstorm Cell Therapeutics Inc: 1 buy, last Dec 30, 2020

Get free alerts when Preetam Shah files a new trade →